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Is Diastolic Heart Failure
Synonymous With Heart Failure
With Preserved Ejection Fraction?
In his excellent Editorial Comment, Dr. Zile states that “heart
failure with a preserved ejection fraction” and “diastolic heart
failure” are synonymous (1). Respectfully, I must disagree. Not all
patients with diastolic heart failure have left ventricular hypertro-
phy. Therefore, the general applicability of the study cited sup-
porting the equivalency of the two terms might be limited because
all patients in that study had echocardiographic evidence for left
ventricular hypertrophy, and diastolic dysfunction is generally
accepted to precede hypertrophy. In our early experience about
one-third of patients with heart failure with a preserved ejection
fraction had explanations for the signs and symptoms of failure
other than diastolic dysfunction, predominately right heart failure
due to pulmonary disease and regurgitant valvular heart disease (2).
The nonspecific nature of the symptoms of heart failure and
iatrogenic volume overload were also noted. It is unclear to what
extent stricter diagnostic criteria for heart failure would affect these
findings, and I believe that our initial criteria would still lead most
clinicians to the diagnosis of heart failure. Furthermore, a patient
with heart failure due to chronic, severe mitral regurgitation with
an ejection fraction of 40% or even 50% has predominately systolic,
not diastolic, heart failure. Therefore, I believe it is best to
conclude that patients with “diastolic heart failure” form a sub-
group of patients with “heart failure with a preserved ejection
fraction.”
Until a uniformly accepted and therapeutically meaningful
measure of diastolic dysfunction is defined, diastolic heart failure is
in many ways a diagnosis of exclusion. The value of initially using
the term “heart failure with preserved, or normal, ejection fraction”
underscores the need to define left ventricular function in virtually
all patients with heart failure (3) as well as the need to carefully
eliminate other cardiac and noncardiac possibilities from the
patient’s signs and symptoms. After eliminating other possibilities,
I agree that the term “diastolic heart failure” seems most appro-
priate, and I hope, as Dr. Zile does, that accepting the term
promotes the investigative efforts that are long overdue for these
patients.
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REPLY
One of the first, if not the first, study to use the term “diastolic
heart failure” was by Dr. Kessler in 1988 (1). His report was truly
innovative and showed remarkable insight into a difficult clinical
problem. I enthusiastically agree with Dr. Kessler’s point of view
and I am grateful to receive his support. In his letter to the editor
of the JACC, he raises three important issues: 1) some patients with
diastolic heart failure do not have left ventricular (LV) hypertro-
phy; 2) the diagnosis of diastolic heart failure should exclude
patients with noncardiac (such as pulmonary disease) and other
cardiac (such as mitral stenosis, regurgitant valve disease) causes of
heart failure; and 3) left ventricular (LV) function must be
measured in every patient with heart failure.
In the study that Dr. Kessler refers to in his letter (2), only about
one-third of the patients had LV hypertrophy defined as LV mass
125 g/m2. However, all patients had concentric hypertrophic
remodeling characterized by a decreased LV end diastolic
volume/mass ratio or LV end diastolic dimension/wall thickness
ratio or an increased relative wall thickness. I believe that a
majority of patients with diastolic heart failure in fact have
either concentric remodeling or some other evidence of myo-
cardial or cardiac structural alterations such as an enlarged left
atrium. With or without concentric remodeling, if a patient
truly has objective signs and symptoms of heart failure and
noncardiac and other cardiac causes have been ruled out, then
heart failure with a normal ejection fraction (EF) is caused by
diastolic dysfunction and the appellation “diastolic heart failure”
should be applied.
Dr. Kessler correctly points out that in patients with primary
right heart failure (caused by chronic lung disease, pulmonic
stenosis, tricuspid regurgitation) or mitral stenosis or left-sided
regurgitant valvular disease, this can result in heart failure with a
normal EF. I am grateful that Dr. Kessler emphasized this point
because our previous publications (2,3) did not make it explicitly
clear that we had in fact excluded patients with noncardiac and
other cardiac causes of heart failure in this study patient cohort.
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